Efficacy of local therapy for oligoprogressive disease after PD-1 blockade in advanced non-small cell lung cancer
Y. Kagawa (Aichi, Japan), T. Uemura (Aichi, Japan), M. Horiuchi (Aichi, Japan), S. Fukuda (Aichi, Japan), K. Maeno (Aichi, Japan), T. Oguri (Aichi, Japan), N. Takeda (Aichi, Japan), K. Fukumitsu (Aichi, Japan), T. Tajiri (Aichi, Japan), H. Ohkubo (Aichi, Japan), Y. Ito (Aichi, Japan), A. Niimi (Aichi, Japan)
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Session: COVID-19 and management of lung cancer
Session type: E-poster
Number: 3855
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kagawa (Aichi, Japan), T. Uemura (Aichi, Japan), M. Horiuchi (Aichi, Japan), S. Fukuda (Aichi, Japan), K. Maeno (Aichi, Japan), T. Oguri (Aichi, Japan), N. Takeda (Aichi, Japan), K. Fukumitsu (Aichi, Japan), T. Tajiri (Aichi, Japan), H. Ohkubo (Aichi, Japan), Y. Ito (Aichi, Japan), A. Niimi (Aichi, Japan). Efficacy of local therapy for oligoprogressive disease after PD-1 blockade in advanced non-small cell lung cancer. 3855
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: